查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1433548

STD診斷市場規模、佔有率、趨勢分析報告：按產品、按應用、按技術、按測試地點、按地區、細分市場預測，2024-2030年

STD Diagnostics Market Size, Share & Trends Analysis Report By Product, By Application, By Technology, By Location Of Testing, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 156 Pages | 商品交期: 2-10個工作天內

價格

性病診斷市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計2024年至2030年全球性病診斷市場規模將以7.18%的複合年成長率成長，2030年將達到163.6億美元。

性行為感染（STD）疾病負擔的增加以及政府和非營利組織為提高意識並鼓勵青少年定期篩檢所做的努力是促進市場成長的關鍵因素。根據世界衛生組織資料，全球每年約有3.74億人新感染梅毒、淋病、披衣菌、披衣菌感染等疾病。

下一代HIV檢測套組和多重PCR產品等先進產品的開發和商業化使醫生能夠及時診斷和區分各種性傳播感染並提供適當的治療。韓國診斷公司 Seegene, Inc. 提供廣泛的 Allplex、Anyplex 和 Seeplex 產品組合，可檢測各種病原體。例如，Allplex STI/BV Panel Assay 可以在一次測試中區分出 28 種病原體。 2022年4月，Seegene, Inc.宣布開發Allplex HPV HR檢測。

Allplex HPV HR 檢測是世界上第一個商業化的「3 Ct」PCR 檢測。 Seegene 專注於將此技術應用於整個產品鏈，包括 STI、尿道感染(UTI) 和呼吸道病毒 (RV) 檢測。這項策略性技術進步預計將為該公司擴大在性行為感染傳染病（STD）診斷行業的佔有率提供額外的優勢。

HIV 國家戰略計畫是 2030 年消除美國人類免疫力缺乏病毒流行的藍圖。該愛滋病毒計畫的實施期限為2021年至2025年，是該國第三個國家愛滋病毒五年計劃，其十年目標是到2030年將新發人類免疫力缺乏病毒感染率減少一半90%。此外，國家病毒性肝炎策略計畫重點關注性傳播B型肝炎和C型肝炎。 2021 年 1 月，美國衛生與公眾服務部 (HHS) 發布了一項國家戰略，以應對病毒性肝炎對美國造成的重大且可預防的公共衛生威脅。政府的有益行動正在為性病診斷產業的擴張創造有利的氛圍。

兩家公司正在做出策略性努力，支持新產品的開發和監管核准，並加強產品系列。例如，2020 年 8 月，DiaSorin, Inc. 獲得美國FDA 的 510(k)核准，推出 LIAISON XL MUREX 抗 HBe。這用於診斷 HBV 感染。此免疫測量產品的工作原理是化學冷光。

性病診斷市場報告亮點

  • 2023年，消耗品領域佔據最大的市場佔有率，並且由於高檢測率和多種STD診斷檢測的商業化，預計在預測期內將保持其地位。
  • 從技術角度來看，由於高通量 PCR 技術的使用增加以及針對 HIV 檢測的 NAAT 檢測的推薦，預計分子診斷領域在預測期內將以最快的複合年成長率成長。同時檢測多種病原體的多重 PCR 檢測的發展也有望促進 STD 診斷產業的成長。
  • 從應用來看，HIV 檢測領域預計將在 2023 年主導性病診斷產業。這是由於愛滋病毒高盛行率、分子檢測產品核可增加以及政府的有利措施等因素所造成的。
  • 由於開發中國家性病檢測率上升、可支配收入增加以及性病患病率較高，亞太國家預計將在預測期內經歷最快的成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章 STD 診斷市場變數、趨勢和範圍

  • 繪製普及和成長前景圖
  • 從使用者觀點分析
  • 監管和報銷框架
  • 市場促進因素分析
    • 全球性行為感染負擔增加
    • 性病診斷技術進步
    • 政府鼓勵早期診斷和治療的舉措
  • 市場限制因素分析
    • 性行為感染疫苗接種範圍
  • COVID-19 影響分析
  • SWOT 分析，按因素（政治/法律、經濟、技術）
  • 產業分析-波特五力分析

第 4 章 STD 診斷市場：細分分析（按產品），2018-2030 年

  • 性病診斷市場：產品波動分析
  • 設備和服務
  • 消耗品
  • 軟體

第5章 STD 診斷市場：按應用細分分析，2018-2030 年

  • 性病診斷市場：應用變化分析
  • CT/NG測試
  • 梅毒測試
  • 單純皰疹病毒檢測
  • HPV檢測
  • 愛滋病毒檢測
  • 解脲支原體和黴漿菌檢測
  • 滴蟲測試
  • VZV測試
  • 戈諾羅耐熱測試
  • 其他考試

第6章 STD 診斷市場：依技術細分分析，2018-2030 年

  • 性病診斷市場：技術變遷分析
  • 分子診斷
  • 免疫檢測
  • 其他

第 7 章 STD 診斷市場：細分分析（按測試地點），2018-2030 年

  • 性病診斷市場：檢測地點的變化分析
  • 臨床檢查
  • 就地檢驗

第 8 章 STD 診斷市場：細分分析，按地區，2018-2030 年

  • 性病診斷市場：按地區分類的展望
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第9章性病診斷市場：競爭分析

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 供應商形勢
  • 2022年主要企業市場佔有率分析
  • 上市公司
  • 私人公司
  • 公司簡介
    • BD
    • F. HOFFMANN-LA ROCHE LTD.
    • HOLOGIC INC. (GEN PROBE)
    • ABBOTT
    • CEPHEID (DANAHER)
    • QIAGEN
    • ORASURE TECHNOLOGIES, INC
    • BIO-RAD LABORATORIES, INC.
    • THERMO FISHER SCIENTIFIC, INC.
    • SEEGENE INC.
    • DIASORIN SPA

第10章結論

Product Code: 978-1-68038-686-8

STD Diagnostics Market Growth & Trends:

The global STD diagnostics market size is expected to reach USD 16.36 billion by 2030, expanding at a CAGR of 7.18% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing disease burden of Sexually Transmitted Disease (STD) and efforts by government & non-profit organizations to increase awareness and encourage regular screenings among the younger population are the key factors augmenting the market growth. According to WHO data, around 374 million new cases of syphilis, gonorrhea, chlamydia, and trichomoniasis are recorded every year globally.

Development and commercialization of advanced products, such as next-generation HIV testing kits and multiplex PCR products, enable physicians to timely diagnose & distinguish a range of STIs and provide appropriate treatment. Seegene, Inc., a South Korea-based diagnostic company, provides a wide portfolio of Allplex, Anyplex, and Seeplex products that detect various causative agents. For instance, Allplex STI/BV Panel Assay can distinguish 28 causative agents in a single test. In April 2022, Seegene, Inc. announced the development of Allplex HPV HR Detection.

Allplex HPV HR Detection is the world's first commercialized '3 Ct' PCR assay. Seegene is focusing to apply this technology to its entire product chain, including STI, Urinary Tract Infection (UTI), and Respiratory Virus (RV) assays. This strategic technological advancement is expected to provide an additional advantage to the company that can help increase its share in the Sexually Transmitted Disease (STD) diagnostics industry.

The HIV National Strategic Plan is a roadmap for eliminating the human immunodeficiency virus pandemic in the U.S. by 2030. The HIV Plan, which will run from 2021 to 2025, is the country's third five-year national HIV plan in a row, with a 10-year goal of halving new human immunodeficiency virus infections by 90% by 2030. Furthermore, the Viral Hepatitis National Strategic Plan focuses on hepatitis B and C, which are sexually transmitted. In January 2021, the US Department of Health and Human Services (HHS) released a nationwide strategy to address the preventable, substantial public health threats posed by viral hepatitis in the United States. The government's beneficial actions create a favorable atmosphere for the expansion of the STD diagnostics industry.

Companies are engaging in strategic initiatives that aid in the development of new products, and regulatory approvals as well as enhance their STD diagnostics product portfolio. For instance, in August 2020, DiaSorin, Inc. received 510 (k) approval from U.S. FDA for introducing LIAISON XL MUREX anti-HBe. It is used for the diagnosis of HBV infection. This immunoassay product works on the principle of chemiluminescence.

STD Diagnostics Market Report Highlights:

  • In 2023, the consumables segment accounted for the largest market share and is anticipated to maintain its position over the forecast period owing to high testing rates for the diagnosis of STDs and the commercialization of several assays
  • Based on technology, the molecular diagnostics segment is estimated to grow at the fastest CAGR during the forecast period owing to the increasing use of high-throughput PCR technology and the recommendation of NAAT tests for HIV testing. The development of multiplex PCR tests for the simultaneous detection of multiple pathogens is also expected to contribute to the STD diagnostics industry's growth
  • Based on application, the HIV testing segment is expected to dominate the STD diagnostics industry in 2023, due to factors such as the high incidence rate of the disease, increasing product approvals for molecular tests, and favorable government initiatives
  • Asia Pacific region is anticipated to experience the fastest growth over the forecast period due to an increase in testing rates for STDS, a rise in disposable income, and high disease prevalence of STD in developing countries

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Segment Scope
    • 1.1.2 Regional Scope
    • 1.1.3 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database:
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach: Commodity Flow Approach
  • 1.7 Research Assumptions
  • 1.8 List Of Secondary Sources
  • 1.9 List Of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1
    • 1.10.2 Objective 2
    • 1.10.3 Objective 3
    • 1.10.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Product And Application Snapshot
  • 2.3 Technology And Location Of Testing Snapshot
  • 2.4 Competitive Snapshot

Chapter 3 STD Diagnostics Market Variables, Trends, And Scope

  • 3.1 Penetration And Growth Prospect Mapping
  • 3.2 User Perspective Analysis
  • 3.3 Regulatory And Reimbursement Framework
  • 3.4 Market Driver Analysis
    • 3.4.1 Growing Global Disease Burden Of STDs
    • 3.4.2 Technological Advancements In STD Diagnostics
    • 3.4.3 Government Initiatives Encouraging Early Diagnosis And Treatment
  • 3.5 Market Restraint Analysis
    • 3.5.1 Vaccination Coverage For STDs
  • 3.6 Covid-19 Impact Analysis
  • 3.7 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
  • 3.8 Industry Analysis - Porter's

Chapter 4 STD Diagnostics Market: Segment Analysis, By Product, 2018 - 2030 (USD Million)

  • 4.1 STD Diagnostics Market: Product Movement Analysis
  • 4.2 Instruments And Services
    • 4.2.1 Instruments And Services Market, 2018 - 2030 (USD Million)
  • 4.3 Consumables
    • 4.3.1 Consumables Market, 2018 - 2030 (USD Million)
  • 4.4 Software
    • 4.4.1 Software Market, 2018 - 2030 (USD Million)

Chapter 5 STD Diagnostics Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)

  • 5.1 STD Diagnostics Market: Application Movement Analysis
  • 5.2 Ct/Ng Testing
    • 5.2.1 Ct/Ng Testing Market, 2018 - 2030 (USD Million)
  • 5.3 Syphilis Testing
    • 5.3.1 Syphilis Testing Market, 2018 - 2030 (USD Million)
    • 5.3.2 Syphilis Pcr Testing Market, 2018 - 2030 (USD Million)
    • 5.3.3 Syphilis Non-Pcr Testing Market, 2018 - 2030 (USD Million)
  • 5.4 Hsv Testing
    • 5.4.1 Hsv Testing Market, 2018 - 2030 (USD Million)
    • 5.4.2 Herpes Simplex Virus Pcr Testing Market, 2018 - 2030 (USD Million)
    • 5.4.3 Herpes Simplex Virus Non-Pcr Testing Market, 2018 - 2030 (USD Million)
  • 5.5 Hpv Testing
    • 5.5.1 Hpv Testing Market, 2018 - 2030 (USD Million)
  • 5.6 Hiv Testing
    • 5.6.1 Human Immunodeficiency Virus Testing Market, 2018 - 2030 (USD Million)
  • 5.7 Ureaplasma & Mycoplasma Testing
    • 5.7.1 Ureaplasma & Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • 5.8 Trichomonas Testing
    • 5.8.1 Trichomonas Testing Market, 2018 - 2030 (USD Million)
  • 5.9 Vzv Testing
    • 5.9.1 Vzv Testing Market, 2018 - 2030 (USD Million)
    • 5.9.2 Vzv Pcr Testing Market, 2018 - 2030 (USD Million)
    • 5.9.3 Vzv Non-Pcr Testing Market, 2018 - 2030 (USD Million)
  • 5.10 Gonorrheatesting
    • 5.10.1 Gonorrhea Testing Market, 2018 - 2030 (USD Million)
  • 5.11 Other Testing
    • 5.11.1 Other Testing Market, 2018 - 2030 (USD Million)

Chapter 6 STD Diagnostics Market: Segment Analysis, By Technology, 2018-2030 (USD Million)

  • 6.1 STD Diagnostics Market: Technology Movement Analysis
  • 6.2 Molecular Diagnostics
    • 6.2.1 Molecular Diagnostics Market, 2018 - 2030 (USD Million)
  • 6.3 Immunoassay
    • 6.3.1 Immunoassay Market, 2018 - 2030 (USD Million)
  • 6.4 Others
    • 6.4.1 Others Market, 2018 - 2030 (USD Million)

Chapter 7 STD Diagnostics Market: Segment Analysis, By Location Of Testing, 2018 - 2030 (USD Million)

  • 7.1 STD Diagnostics Market: Location Of Testing Movement Analysis
  • 7.2 Laboratory Testing
    • 7.2.1 Laboratory Testing Market, 2018 - 2030 (USD Million)
    • 7.2.2 Commercial/Private Labs
      • 7.2.2.1 Commercial/Private Labs Market, 2018 - 2030 (USD Million)
    • 7.2.3 Public Health Labs
      • 7.2.3.1 Public Health Labs Market, 2018 - 2030 (USD Million)
  • 7.3 Point Of Care Testing
    • 7.3.1 Point Of Care Testing Market, 2018 - 2030 (USD Million)

Chapter 8 STD Diagnostics Market: Segment Analysis, By Region, 2018 - 2030 (USD Million)

  • 8.1 STD Diagnostics Market: Regional Outlook
  • 8.2 North America
    • 8.2.1 North America STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2 U.S.
      • 8.2.2.1 Key Country Dynamics
      • 8.2.2.2 U.S. STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.2.2.3 Target Disease: Cancer Incidence
      • 8.2.2.4 Market And Competitive Scenario
      • 8.2.2.5 Regulatory Framework
      • 8.2.2.6 Reimbursement Scenario
    • 8.2.3 Canada
      • 8.2.3.1 Key Country Dynamics
      • 8.2.3.2 Canada STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.2.3.3 Target Disease: Cancer Incidence
      • 8.2.3.4 Market And Competitive Scenario
      • 8.2.3.5 Regulatory Framework
      • 8.2.3.6 Reimbursement Scenario
  • 8.3 Europe
    • 8.3.1 Europe STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2 UK
      • 8.3.2.1 Key Country Dynamics
      • 8.3.2.2 Uk STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.2.3 Target Disease Prevalence
      • 8.3.2.4 Market And Competitive Scenario
      • 8.3.2.5 Regulatory Framework
      • 8.3.2.6 Reimbursement Scenario
    • 8.3.3 Germany
      • 8.3.3.1 Key Country Dynamics
      • 8.3.3.2 Germany STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.3.3 Target Disease Prevalence
      • 8.3.3.4 Market And Competitive Scenario
      • 8.3.3.5 Regulatory Framework
      • 8.3.3.6 Reimbursement Scenario
    • 8.3.4 France
      • 8.3.4.1 Key Country Dynamics
      • 8.3.4.2 France STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.4.3 Target Disease Prevalence
      • 8.3.4.4 Market And Competitive Scenario
      • 8.3.4.5 Regulatory Framework
      • 8.3.4.6 Reimbursement Scenario
    • 8.3.5 Spain
      • 8.3.5.1 Key Country Dynamics
      • 8.3.5.2 Spain STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.5.3 Target Disease Prevalence
      • 8.3.5.4 Market And Competitive Scenario
      • 8.3.5.5 Regulatory Framework
      • 8.3.5.6 Reimbursement Scenario
    • 8.3.6 Italy
      • 8.3.6.1 Key Country Dynamics
      • 8.3.6.2 Italy STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.6.3 Target Disease Prevalence
      • 8.3.6.4 Market And Competitive Scenario
      • 8.3.6.5 Regulatory Framework
      • 8.3.6.6 Reimbursement Scenario
    • 8.3.7 Denmark
      • 8.3.7.1 Key Country Dynamics
      • 8.3.7.2 Denmark STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.7.3 Target Disease Prevalence
      • 8.3.7.4 Market And Competitive Scenario
      • 8.3.7.5 Regulatory Framework
      • 8.3.7.6 Reimbursement Scenario
    • 8.3.8 Sweden
      • 8.3.8.1 Key Country Dynamics
      • 8.3.8.2 Sweden STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.8.3 Target Disease Prevalence
      • 8.3.8.4 Market And Competitive Scenario
      • 8.3.8.5 Regulatory Framework
      • 8.3.8.6 Reimbursement Scenario
    • 8.3.9 Norway
      • 8.3.9.1 Key Country Dynamics
      • 8.3.9.2 Norway STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.9.3 Target Disease Prevalence
      • 8.3.9.4 Market And Competitive Scenario
      • 8.3.9.5 Regulatory Framework
      • 8.3.9.6 Reimbursement Scenario
    • 8.3.10 Rest Of Europe STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Asia Pacific STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2 Japan
      • 8.4.2.1 Key Country Dynamics
      • 8.4.2.2 Japan STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.4.2.3 Target Disease Prevalence
      • 8.4.2.4 Market And Competitive Scenario
      • 8.4.2.5 Regulatory Framework
      • 8.4.2.6 Reimbursement Scenario
    • 8.4.3 China
      • 8.4.3.1 Key Country Dynamics
      • 8.4.3.2 China STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.4.3.3 Target Disease Prevalence
      • 8.4.3.4 Market And Competitive Scenario
      • 8.4.3.5 Regulatory Framework
      • 8.4.3.6 Reimbursement Scenario
    • 8.4.4 India
      • 8.4.4.1 Key Country Dynamics
      • 8.4.4.2 India STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.4.4.3 Target Disease Prevalence
      • 8.4.4.4 Market And Competitive Scenario
      • 8.4.4.5 Regulatory Framework
      • 8.4.4.6 Reimbursement Scenario
    • 8.4.5 Australia
      • 8.4.5.1 Key Country Dynamics
      • 8.4.5.2 Australia STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.4.5.3 Target Disease Prevalence
      • 8.4.5.4 Market And Competitive Scenario
      • 8.4.5.5 Regulatory Framework
      • 8.4.5.6 Reimbursement Scenario
    • 8.4.6 Thailand
      • 8.4.6.1 Key Country Dynamics
      • 8.4.6.2 Thailand STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.4.6.3 Target Disease Prevalence
      • 8.4.6.4 Market And Competitive Scenario
      • 8.4.6.5 Regulatory Framework
      • 8.4.6.6 Reimbursement Scenario
    • 8.4.7 South Korea
      • 8.4.7.1 Key Country Dynamics
      • 8.4.7.2 South Korea STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.4.7.3 Target Disease Prevalence
      • 8.4.7.4 Market And Competitive Scenario
      • 8.4.7.5 Regulatory Framework
      • 8.4.7.6 Reimbursement Scenario
    • 8.4.8 Rest Of Asia Pacific STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Latin America STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2 Brazil
      • 8.5.2.1 Key Country Dynamics
      • 8.5.2.2 Brazil STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.5.2.3 Target Disease Prevalence
      • 8.5.2.4 Competitive Scenario
      • 8.5.2.5 Regulatory Framework
      • 8.5.2.6 Reimbursement Scenario
    • 8.5.3 Mexico
      • 8.5.3.1 Key Country Dynamics
      • 8.5.3.2 Mexico STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.5.3.3 Target Disease Prevalence
      • 8.5.3.4 Competitive Scenario
      • 8.5.3.5 Regulatory Framework
      • 8.5.3.6 Reimbursement Scenario
    • 8.5.4 Argentina
      • 8.5.4.1 Key Country Dynamics
      • 8.5.4.2 Argentina STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.5.4.3 Target Disease Prevalence
      • 8.5.4.4 Competitive Scenario
      • 8.5.4.5 Regulatory Framework
      • 8.5.4.6 Reimbursement Scenario
    • 8.5.5 Rest Of Latin America STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6 Mea
    • 8.6.1 Mea STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2 South Africa
      • 8.6.2.1 Key Country Dynamics
      • 8.6.2.2 South Africa STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.6.2.3 Target Disease Prevalence
      • 8.6.2.4 Competitive Scenario
      • 8.6.2.5 Regulatory Framework
      • 8.6.2.6 Reimbursement Scenario
    • 8.6.3 Saudi Arabia
      • 8.6.3.1 Key Country Dynamics
      • 8.6.3.2 Saudi Arabia STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.6.3.3 Target Disease Prevalence
      • 8.6.3.4 Competitive Scenario
      • 8.6.3.5 Regulatory Framework
      • 8.6.3.6 Reimbursement Scenario
    • 8.6.4 UAE
      • 8.6.4.1 Key Country Dynamics
      • 8.6.4.2 Uae STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.6.4.3 Target Disease Prevalence
      • 8.6.4.4 Competitive Scenario
      • 8.6.4.5 Regulatory Framework
      • 8.6.4.6 Reimbursement Scenario
    • 8.6.5 Kuwait
      • 8.6.5.1 Key Country Dynamics
      • 8.6.5.2 Kuwait STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.6.5.3 Target Disease Prevalence
      • 8.6.5.4 Competitive Scenario
      • 8.6.5.5 Regulatory Framework
      • 8.6.5.6 Reimbursement Scenario
    • 8.6.6 Rest Of Mea STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 9 STD Diagnostics Market: Competitive Analysis

  • 9.1 Recent Developments And Impact Analysis, By Key Market Participants
    • 9.1.1 New Product Launches
    • 9.1.2 Mergers And Acquisitions
    • 9.1.3 Partnerships And Strategic Collaboration
    • 9.1.4 Conferences And Campaigns
  • 9.2 Company Categorization
    • 9.2.1 Innovators
    • 9.2.2 Market Leaders
    • 9.2.3 Heat Map Analysis
  • 9.3 Vendor Landscape
    • 9.3.1 List Of Key Distributors And Channel Partners
    • 9.3.2 Key Customers
  • 9.4 Key Company Market Share Analysis, 2022
  • 9.5 Public Companies
    • 9.5.1 Company Market Position Analysis
    • 9.5.2 Competitive Dashboard Analysis
      • 9.5.2.1 Market Differentiators
  • 9.6 Private Companies
    • 9.6.1 List Of Key Emerging Companies
    • 9.6.2 Regional Network Map
  • 9.7 Company Profiles
    • 9.7.1 BD
      • 9.7.1.1 Company Overview
      • 9.7.1.2 Financial Performance
      • 9.7.1.3 Product benchmarking
      • 9.7.1.4 Strategic initiatives
    • 9.7.2 F. HOFFMANN-LA ROCHE LTD.
      • 9.7.2.1 Company overview
      • 9.7.2.2 Financial Performance
      • 9.7.2.3 Product benchmarking
      • 9.7.2.4 Strategic initiatives
    • 9.7.3 HOLOGIC INC. (GEN PROBE)
      • 9.7.3.1 Company Overview
      • 9.7.3.2 Financial Performance
      • 9.7.3.3 Product Benchmarking
      • 9.7.3.4 Strategic Initiatives
    • 9.7.4 ABBOTT
      • 9.7.4.1 Company Overview
      • 9.7.4.2 Financial Performance
      • 9.7.4.3 Product Benchmarking
      • 9.7.4.4 Strategic Initiatives
    • 9.7.5 CEPHEID (DANAHER)
      • 9.7.5.1 Company Overview
      • 9.7.5.2 Financial Performance
      • 9.7.5.3 Product Benchmarking
      • 9.7.5.4 Strategic Initiatives
    • 9.7.6 QIAGEN
      • 9.7.6.1 Company Overview
      • 9.7.6.2 Financial Performance
      • 9.7.6.3 Product Benchmarking
      • 9.7.6.4 Strategic Initiatives
    • 9.7.7 ORASURE TECHNOLOGIES, INC
      • 9.7.7.1 Company Overview
      • 9.7.7.2 Financial Performance
      • 9.7.7.3 Product Benchmarking
      • 9.7.7.4 Strategic Initiatives
    • 9.7.8 BIO-RAD LABORATORIES, INC.
      • 9.7.8.1 Company Overview
      • 9.7.8.2 Financial Performance
      • 9.7.8.3 Product Benchmarking
      • 9.7.8.4 Strategic Initiatives
    • 9.7.9 BIOMERIEUX SA
      • 9.7.9.1 Company overview
      • 9.7.9.2 Financial Performance
      • 9.7.9.3 Product benchmarking
      • 9.7.9.4 Strategic initiatives
    • 9.7.10 THERMO FISHER SCIENTIFIC, INC.
      • 9.7.10.1 Company overview
      • 9.7.10.2 Financial performance
      • 9.7.10.3 Product benchmarking
      • 9.7.10.4 Strategic initiatives
    • 9.7.11 SEEGENE INC.
      • 9.7.11.1 Company overview
      • 9.7.11.2 Financial performance
      • 9.7.11.3 Product benchmarking
      • 9.7.11.4 Strategic initiatives
    • 9.7.12 DIASORIN S.P.A
      • 9.7.12.1 Company overview
      • 9.7.12.2 Financial performance
      • 9.7.12.3 Product benchmarking
      • 9.7.12.4 Strategic initiatives

Chapter 10 Conclusion

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviations
  • Table 3 List of key distributors
  • Table 4 List of other companies
  • Table 5 List of key emerging companies/technology disruptors/innovators
  • Table 6 Global STD Diagnostics Market, By Region, 2018 - 2030 (USD Million)
  • Table 7 Global STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 8 Global STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 9 Global STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 10 Global STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 11 North America STD Diagnostics Market, By Country, 2018 - 2030 (USD Million)
  • Table 12 North America STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 13 North America STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 14 North America STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 15 North America STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 16 U.S. STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 17 U.S. STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 18 U.S. STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 19 U.S. STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 20 Canada STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 21 Canada STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 22 Canada STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 23 Canada STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 24 Europe STD Diagnostics Market, By Country, 2018 - 2030 (USD Million)
  • Table 25 Europe STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 26 Europe STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 27 Europe STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 28 Europe STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 29 UK STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 30 UK STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 31 UK STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 32 UK STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 33 Germany STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 34 Germany STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 35 Germany STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 36 Germany STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 37 France STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 38 France STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 39 France STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 40 France STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 41 Spain STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 42 Spain STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 43 Spain STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 44 Spain STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 45 Italy STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 46 Italy STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 47 Italy STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 48 Italy STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 49 Denmark STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 50 Denmark STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 51 Denmark STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 52 Denmark STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 53 Sweden STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 54 Sweden STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 55 Sweden STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 56 Sweden STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 57 Norway STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 58 Norway STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 59 Norway STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 60 Norway STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific STD Diagnostics Market, By Country, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 66 Japan STD Diagnostics Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 67 Japan STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 68 Japan STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 69 Japan STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 70 China STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 71 China STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 72 China STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 73 China STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 74 India STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 75 India STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 76 India STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 77 India STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 78 Australia STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 79 Australia STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 80 Australia STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 81 Australia STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 82 South Korea STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 83 South Korea STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 84 South Korea STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 85 South Korea STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 86 Thailand STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 87 Thailand STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 88 Thailand STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 89 Thailand STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 90 Latin America STD Diagnostics Market, By Country, 2018 - 2030 (USD Million)
  • Table 91 Latin America STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 92 Latin America STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 93 Latin America STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 94 Latin America STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 95 Brazil STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 96 Brazil STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 97 Brazil STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 98 Brazil STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 99 Mexico STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 100 Mexico STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 101 Mexico STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 102 Mexico STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 103 Argentina STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 104 Argentina STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 105 Argentina STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 106 Argentina STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 107 MEA STD Diagnostics Market, By Country, 2018 - 2030 (USD Million)
  • Table 108 MEA STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 109 MEA STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 110 MEA STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 111 MEA STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 112 South Africa STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 113 South Africa STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 114 South Africa STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 115 South Africa STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 117 Saudi Arabia STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 118 Saudi Arabia STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 119 Saudi Arabia STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 120 UAE STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 121 UAE STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 122 UAE STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 123 UAE STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
  • Table 124 Kuwait STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 125 Kuwait STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 126 Kuwait STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 127 Kuwait STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 STD Diagnostics Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2023)
  • Fig. 10 Penetration and growth prospect mapping
  • Fig. 11 User perspective analysis
  • Fig. 12 STD Diagnostics Market driver impact
  • Fig. 13 Prevalence of STIs by WHO regions (in 2023)
  • Fig. 14 STD Diagnostics Market restraint impact
  • Fig. 15 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
  • Fig. 16 Porter's Five Forces Analysis
  • Fig. 17 STD diagnostics product outlook: Key takeaways
  • Fig. 18 STD Diagnostics Market: Product movement analysis
  • Fig. 19 Instruments and Services market, 2018 - 2030 (USD Million)
  • Fig. 20 Consumables market, 2018 - 2030 (USD Million)
  • Fig. 21 Software market, 2018 - 2030 (USD Million)
  • Fig. 22 STD diagnostics application outlook: Key takeaways
  • Fig. 23 STD Diagnostics Market: Application movement analysis
  • Fig. 24 CT/NG testing market, 2018 - 2030 (USD Million)
  • Fig. 25 Prevalence (%) of syphilis by WHO regions
  • Fig. 26 Syphilis testing market, 2018 - 2030 (USD Million)
  • Fig. 27 Syphilis PCR testing market, 2018 - 2030 (USD Million)
  • Fig. 28 Syphilis non-PCR testing market, 2018 - 2030 (USD Million)
  • Fig. 29 HSV testing market, 2018 - 2030 (USD Million)
  • Fig. 30 Herpes Simplex Virus PCR testing market, 2018 - 2030 (USD Million)
  • Fig. 31 Herpes Simplex Virus non-PCR testing market, 2018 - 2030 (USD Million)
  • Fig. 32 HPV testing market, 2018 - 2030 (USD Million)
  • Fig. 33 Prevalence (%) of HIV by WHO regions
  • Fig. 34 HIV testing market, 2018 - 2030 (USD Million)
  • Fig. 35 Ureaplasma & mycoplasma testing market, 2018 - 2030 (USD Million)
  • Fig. 36 Trichomonas testing market, 2018 - 2030 (USD Million)
  • Fig. 37 VZV testing market, 2018 - 2030 (USD Million)
  • Fig. 38 VZV PCR testing market, 2018 - 2030 (USD Million)
  • Fig. 39 VZV non-PCR testing market, 2018 - 2030 (USD Million)
  • Fig. 40 Other testing market, 2018 - 2030 (USD Million)
  • Fig. 41 STD diagnostics technology outlook: Key takeaways
  • Fig. 42 STD Diagnostics Market: Technology movement analysis
  • Fig. 43 Molecular Diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 44 Immunoassay market, 2018 - 2030 (USD Million)
  • Fig. 45 Others market, 2018 - 2030 (USD Million)
  • Fig. 46 STD diagnostics location of testing outlook: Key takeaways
  • Fig. 47 STD Diagnostics Market: Location of testing movement analysis
  • Fig. 48 Laboratory testing market, 2018 - 2030 (USD Million)
  • Fig. 49 Commercial/private labs market, 2018 - 2030 (USD Million)
  • Fig. 50 Public health labs market, 2018 - 2030 (USD Million)
  • Fig. 51 Point of care testing market, 2018 - 2030 (USD Million)
  • Fig. 52 Regional outlook, 2023 & 2030
  • Fig. 53 Regional marketplace: Key takeaways
  • Fig. 54 North America SWOT
  • Fig. 55 North America STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 56 U.S. Country Dynamics
  • Fig. 57 U.S. Target Disease Prevalence
  • Fig. 58 U.S. STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 59 Canada Country Dynamics
  • Fig. 60 Canada Target Disease Prevalence
  • Fig. 61 Canada STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 62 Europe SWOT
  • Fig. 63 Europe STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 64 UK Country Dynamics
  • Fig. 65 UK Target Disease Prevalence
  • Fig. 66 UK STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 67 Germany Country Dynamics
  • Fig. 68 GermanyTarget Disease Prevalence
  • Fig. 69 Germany STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 70 France Country Dynamics
  • Fig. 71 France Target Disease Prevalence
  • Fig. 72 France STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 73 Spain Country Dynamics
  • Fig. 74 Spain Target Disease Prevalence
  • Fig. 75 Spain STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 76 Italy Country Dynamics
  • Fig. 77 Italy Target Disease Prevalence
  • Fig. 78 Italy STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 79 Denmark Country Dynamics
  • Fig. 80 Denmark Target Disease Prevalence
  • Fig. 81 Denmark STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 82 Sweden Country Dynamics
  • Fig. 83 Sweden Target Disease Prevalence
  • Fig. 84 Sweden STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 85 Denmark Country Dynamics
  • Fig. 86 Denmark Target Disease Prevalence
  • Fig. 87 Denmark STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 88 Asia Pacific SWOT
  • Fig. 89 Asia Pacific STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 90 Japan Country Dynamics
  • Fig. 91 Japan Target Disease Prevalence
  • Fig. 92 Japan STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 93 China Country Dynamics
  • Fig. 94 China Target Disease Prevalence
  • Fig. 95 China STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 96 India Country Dynamics
  • Fig. 97 India Target Disease Prevalence
  • Fig. 98 India STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 99 Australia Country Dynamics
  • Fig. 100 Australia Target Disease Prevalence
  • Fig. 101 Australia STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 102 South Korea Country Dynamics
  • Fig. 103 South Korea Target Disease Prevalence
  • Fig. 104 South Korea STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 105 Thailand Country Dynamics
  • Fig. 106 Thailand Target Disease Prevalence
  • Fig. 107 Thailand STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 108 Latin America SWOT
  • Fig. 109 Latin America STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 110 Brazil Country Dynamics
  • Fig. 111 Brazil Target Disease Prevalence
  • Fig. 112 Brazil STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 113 Mexico Country Dynamics
  • Fig. 114 Mexico Target Disease Prevalence
  • Fig. 115 Mexico STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 116 Argentina Country Dynamics
  • Fig. 117 Argentina Target Disease Prevalence
  • Fig. 118 Argentina STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 119 Middle East & Africa SWOT
  • Fig. 120 Middle East & Africa STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 121 South Africa Country Dynamics
  • Fig. 122 South Africa Target Disease Prevalence
  • Fig. 123 South Africa STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 124 Saudi Arabia Country Dynamics
  • Fig. 125 Saudi Arabia Target Disease Prevalence
  • Fig. 126 Saudi Arabia STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 127 UAE Country Dynamics
  • Fig. 128 UAE Target Disease Prevalence
  • Fig. 129 UAE STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 130 Kuwait Country Dynamics
  • Fig. 131 Kuwait Target Disease Prevalence
  • Fig. 132 Kuwait STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 133 Heat map analysis
  • Fig. 134 Company market share analysis (2023)
  • Fig. 135 Company market position analysis (2023)
  • Fig. 136 Company market position analysis (2023)
  • Fig. 137 Market differentiators
  • Fig. 138 Regional Network Map